These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3071251)

  • 1. Mendelian hyperphenylalaninemia.
    Scriver CR; Kaufman S; Woo SL
    Annu Rev Genet; 1988; 22():301-21. PubMed ID: 3071251
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenylketonuria and other phenylalanine hydroxylation mutants in man.
    Scriver CR; Clow CL
    Annu Rev Genet; 1980; 14():179-202. PubMed ID: 7011173
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular heterogeneity of nonphenylketonuria hyperphenylalaninemia in 25 Danish patients.
    Guldberg P; Henriksen KF; Thöny B; Blau N; Güttler F
    Genomics; 1994 May; 21(2):453-5. PubMed ID: 8088845
    [No Abstract]   [Full Text] [Related]  

  • 4. Review of current practices in management of inherited disorders of amino acid metabolism in Western Europe.
    Wachtel U
    Hum Nutr Appl Nutr; 1986; 40 Suppl 1():61-9. PubMed ID: 3528074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood.
    Güttler F
    Acta Paediatr Scand Suppl; 1980; 280():1-80. PubMed ID: 7006308
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular basis of phenylketonuria and related hyperphenylalaninemias: mutations and polymorphisms in the human phenylalanine hydroxylase gene.
    Eisensmith RC; Woo SL
    Hum Mutat; 1992; 1(1):13-23. PubMed ID: 1301187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Classification and heterogeneity of hyperphenylalaninemias linked to a phenylalanine hydroxylase deficiency].
    Rey F; Munnich A; Lyonnet S; Rey J
    Arch Fr Pediatr; 1987; 44 Suppl 1():639-42. PubMed ID: 3329492
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current aspects of hyperphenylalaninemia].
    Segrè A; Giovannini M; Riva E
    Minerva Pediatr; 1977 Apr; 29(15):1037-46. PubMed ID: 17825
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional and structural characterization of novel mutations and genotype-phenotype correlation in 51 phenylalanine hydroxylase deficient families from Southern Italy.
    Daniele A; Scala I; Cardillo G; Pennino C; Ungaro C; Sibilio M; Parenti G; Esposito L; Zagari A; Andria G; Salvatore F
    FEBS J; 2009 Apr; 276(7):2048-59. PubMed ID: 19292873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two missense mutations causing mild hyperphenylalaninemia associated with DNA haplotype 12.
    Svensson E; Eisensmith RC; Dworniczak B; von Döbeln U; Hagenfeldt L; Horst J; Woo SL
    Hum Mutat; 1992; 1(2):129-37. PubMed ID: 1301200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydropteridine reductase deficiency: physical structure of the QDPR gene, identification of two new mutations and genotype-phenotype correlations.
    Dianzani I; de Sanctis L; Smooker PM; Gough TJ; Alliaudi C; Brusco A; Spada M; Blau N; Dobos M; Zhang HP; Yang N; Ponzone A; Armarego WL; Cotton RG
    Hum Mutat; 1998; 12(4):267-73. PubMed ID: 9744478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The enzymes of the hepatic phenylalanine hydroxylating system.
    Kaufman S
    J Inherit Metab Dis; 1978; 1(2):63-5. PubMed ID: 117244
    [No Abstract]   [Full Text] [Related]  

  • 13. Different clinical manifestations of hyperphenylalaninemia in three siblings with identical phenylalanine hydroxylase genes.
    DiSilvestre D; Koch R; Groffen J
    Am J Hum Genet; 1991 May; 48(5):1014-6. PubMed ID: 2018035
    [No Abstract]   [Full Text] [Related]  

  • 14. Issues for consideration in dihydropteridine reductase (DHPR) deficiency: a variant form of hyperphenylalaninaemia.
    Pogson D
    J Intellect Disabil Res; 1997 Jun; 41 ( Pt 3)():208-14. PubMed ID: 9219069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic disorders involving recycling and formation of tetrahydrobiopterin.
    Kaufman S
    Adv Pharmacol; 1998; 42():41-3. PubMed ID: 9327841
    [No Abstract]   [Full Text] [Related]  

  • 16. Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: implications for tetrahydrobiopterin-responsive hyperphenylalaninemia.
    Thöny B; Ding Z; Martínez A
    FEBS Lett; 2004 Nov; 577(3):507-11. PubMed ID: 15556637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of permanent brain dysfunction in hyperphenylalaninemia.
    Hommes FA
    Biochem Med Metab Biol; 1991 Dec; 46(3):277-87. PubMed ID: 1793607
    [No Abstract]   [Full Text] [Related]  

  • 18. Nature of the molecular defect in phenylketonuria and hyperphenylalaninaemia.
    Friedman PA; Kaufman S; Kang ES
    Nature; 1972 Nov; 240(5377):157-9. PubMed ID: 4118080
    [No Abstract]   [Full Text] [Related]  

  • 19. Genotype-phenotype correlation in dihydropteridine reductase deficiency.
    de Sanctis L; Alliaudi C; Spada M; Farrugia R; Cerone R; Biasucci G; Meli C; Zammarchi E; Coskun T; Blau N; Ponzone A; Dianzani I
    J Inherit Metab Dis; 2000 Jun; 23(4):333-7. PubMed ID: 10896287
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutation at the phenylalanine hydroxylase gene (PAH) and its use to document population genetic variation: the Quebec experience.
    Carter KC; Byck S; Waters PJ; Richards B; Nowacki PM; Laframboise R; Lambert M; Treacy E; Scriver CR
    Eur J Hum Genet; 1998 Jan; 6(1):61-70. PubMed ID: 9781015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.